{"description":"This study is retrospective and observational in nature, it involves data that exist as structured data by the time of study start. The minimum criteria for reporting an adverse event (AE) (i.e., identifiable participant, identifiable reporter, a suspect product, and event) cannot be met. Hence, adverse events were not planned to be evaluated and explains 0 at risk.","eventGroups":[{"deathsNumAffected":54,"deathsNumAtRisk":118,"description":"Eligible participants with TCR-MM, who were BCMA naïve, who initiated elranatamab (PF-06863135) following TCR eligibility in study C1071003 (NCT04649359) Cohort A were included.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"C1071003 Cohort A"},{"deathsNumAffected":128,"deathsNumAtRisk":277,"description":"Eligible participants with TCR-MM who initiated SOC treatment and were identified from TM-MM database in real world setting under routine clinical practice outside of clinical trials were included. This arm served as external control arm.","id":"EG001","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"RWD: TM-MM Database"},{"deathsNumAffected":150,"deathsNumAtRisk":238,"description":"Eligible participants with TCR-MM who initiated SOC treatment and were identified from Flatiron Health database in real world setting under routine clinical practice outside of clinical trials were included. This arm served as external control arm.","id":"EG002","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"RWD: Flatiron Health Database"}],"frequencyThreshold":"0","timeFrame":"All-cause mortality: During follow-up duration of approximately 25.08 months for C1071003, 50.64 months for RWD: TM-MM database and 77.4 months for RWD: Flatiron Health database; available retrospective data was evaluated in this observational study for approximately 9 months; for adverse events it was not applicable as adverse event data was not planned to be evaluated"}